Document is current
Any future updates will be listed below
-
Authors
Su, Chengxun https://orcid.org/0000-0001-6723-693X
Wang, Peter https://orcid.org/0000-0002-4925-1738
Foo, Nigel https://orcid.org/0009-0004-3017-8261
-
Funding
Funding for this research was provided by:
Institute for Digital Medicine Translational Research Programme (A-0001319-00-00)
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 7 March 2025
First Online: 24 March 2025
Competing interests
: D.H. is one of the inventors of previously filed pending patents on artificial intelligence-based therapy development. D.H. is a co-founder and shareholder of KYAN Therapeutics, which is commercializing intellectual property pertaining to AI-based personalized medicine. The remaining authors declare no competing interests.
